Antiviral agents are a class of medications designed to inhibit the replication of viruses, preventing their spread within the body. These agents target specific stages of the viral life cycle, such as viral entry, genome replication, or protein synthesis. Common antiviral drug classes include nucleoside/nucleotide analogs, protease inhibitors, polymerase inhibitors, and neuraminidase inhibitors. Antiviral agents are crucial in the treatment of viral infections, including influenza, herpes, HIV, hepatitis, and respiratory viruses. They can either directly interfere with viral replication or stimulate the immune system's response to eliminate infected cells. Antiviral therapy has been particularly significant in managing chronic viral infections like HIV, allowing individuals to lead healthier lives. The development of antiviral agents has also played a pivotal role in controlling and preventing viral outbreaks. While antiviral agents have demonstrated effectiveness, challenges include the emergence of drug-resistant viral strains and potential side effects. Ongoing research focuses on the discovery of new antiviral drugs, understanding viral resistance mechanisms, and exploring combination therapies to enhance efficacy and reduce the risk of resistance.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan